Waters acquires Halo Labs, expanding biological analysis portfolio
Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies
Waters has acquired Halo Labs™ to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies
As India starts to tackle PFAS, CSIR-IITR is leading the charge in developing detection methods using Waters’ advanced technologies
Discover the lab instruments Dr Parrington couldn't do his research without
Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays
Thermo Fisher Scientific, Sony Biotechnology, and Logos Biosystems among those recognized
A compact benchtop optofluidic system with lower cost of ownership for broader research accessibility
Normally an insulator, diamond becomes a metallic conductor when subjected to large strain in a new theoretical model
In this guest editorial, Dr. Katherine Bridge, University of York, explains how aptamers could unlock new opportunities for more targeted and effective cancer treatments
GutID is the first microbiome test able to identify all bacteria in the gut at the strain level and could help manage and prevent a wide range of diseases
A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine
Explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries
From spreadsheet silos to AI-powered insights, discover how Signals software is streamlining formulation science
Miniaturization and automated liquid handling transform NGS workflows for precious sample processing
Closthioamide, discovered in 2010, might eventually offer an alternative for current drugs that are becoming less effective against gonorrhoea.